IBM Watson to Boost Pharma R&D and Reduce Costs

  IBM Watson is taking research to levels of speed unreachable by humans IBM announced last week the next step in Watson Discovery Advisor’s cognitive computing capabilities. Now available as a cloud service, it is already showing its potential to help research teams in all sectors accelerate research and discovery processes, by quickly analysing data in millions of scientific papers …

Isn’t it logical that drug repurposing can recover Pharma’s decreasing revenue?

If it's clear that the number of NCEs have not increased in the past decade and pharma's revenues have been eroded by lost of patent protection for major drugs, why isn't the industry giving more emphasis to drug repositioning? When aggregated costs from putting a single drug in the market varies from $0.6-$1.5 billion, the opportunity of giving new life …